Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | CRHBP | P24387 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | JAK1 | P23458 | 4/20 | 0.43 |
| ▸ | CDK1 | P06493 | 2/20 | 0.43 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.43 |
| ▸ | CDK2 | P24941 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | NCOR1 | O75376 | 1/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28097875 | 0.99 | KMT2A (0.44) | KMT2AMEN1CRHBPHTTCRHR2 | |
| Hydrochloric Acid SCHEMBL28091776 | 0.90 | KMT2A (0.38) | KMT2AMEN1CRHBPHTTCRHR2 | |
| SCHEMBL28820764 | 0.81 | HSD17B10 (0.43) | HTTSMN1; SMN2HDAC2HDAC3HDAC1 | |
| SCHEMBL4819312 | 0.81 | POLB (0.43) | KMT2AMEN1CRHBPHTTCRHR2 | |
| SCHEMBL7389800 | 0.81 | ACHE (0.43) | KMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL7391494 | 0.79 | ACHE (0.38) | KMT2AHTTHDAC2HDAC3HDAC1 | |
| SCHEMBL5262422 | 0.77 | L3MBTL1 (0.46) | KMT2AMEN1HTTSMN1; SMN2POLB | |
| SCHEMBL15142461 | 0.77 | ITGB1 (0.51) | — | |
| SCHEMBL29019451 | 0.76 | RXFP1 (0.41) | KMT2AHDAC2HDAC3HDAC1HDAC6 | |
| SCHEMBL28449499 | 0.76 | PKM (0.45) | KMT2AMEN1HTTSMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1700850-B1 | Phenylalanine derivative | AJINOMOTO KK (JP) | 2015-07-15 | — | — | EP | disclosed |
| EP-2803667-A1 | Phenylalanine derivatives | AJINOMOTO CO., INC. (JP) | 2014-11-19 | — | — | EP | disclosed |
| EP-2615087-A2 | Phenylalanine derivatives | AJINOMOTO CO., INC. (JP) | 2013-07-17 | — | — | EP | disclosed |
| EP-1916241-B1 | CRYSTAL OF PHENYLALANINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME AND USE THEREOF | AJINOMOTO KK (JP) | 2013-06-12 | — | — | EP | disclosed |
| US-8309561-B2 | N-(2,6-dichlorobenzoyl)-4-[1-methyl-7-(pyrrolidine-1-ylmethyl)-2,4-quinazoline-dione-3-yl]-L-phenylalanine trifluoroacetate; 4 integrin antagonist; antiinflammatory, anticarcinogenic agent, antiallergent; asthma, psoriasis, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation | AJINOMOTO CO., INC. (JP) | 2012-11-13 | — | — | US | disclosed |
| US-8268844-B2 | Crystals of isopropyl ester of N-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl-1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2H)-yl]-l-phenylalanine hydrochloride, production method thereof and use thereof | AJINOMOTO CO., INC. (JP) | 2012-09-18 | — | — | US | disclosed |
| EP-2402326-A1 | Crystals of hydrochloride salts of a Phenylalanine Derivative, Production Method Thereof and Use Thereof as alpha4 integrin Inhibitors | Ajinomoto Co., Inc. (JP) | 2012-01-04 | — | — | EP | disclosed |
| US-20110009434-A1 | CRYSTALS OF ISOPROPYL ESTER OF N-(2,6-DICHLOROBENZOYL)-4-[6-(METHYLAMINO)METHYL -1-METHYL-2,4-DIOXO-1,4-DIHYDROQUINAZOLINE-3(2H)-YL]-L- PHENYLALANINE HYDROCHLORIDE, PRODUCTION METHOD THEREOF AND USE THEREOF | AJINOMOTO CO., INC. (JP) | 2011-01-13 | — | — | US | disclosed |
| US-7842700-B2 | Crystals of isopropyl ester of N-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl-1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2H)-yl]-L-phenylalanine hydrochloride, production method thereof and use thereof | AJINOMOTO CO., INC. (JP) | 2010-11-30 | — | — | US | disclosed |
| US-20080108637-A1 | CRYSTALS OF PHENYLALANINE DERIVATIVES, PRODUCTION METHOD THEREOF AND USE THEREOF | AJINOMOTO CO., INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| US-20080108634-A1 | NOVEL PHENYLALANINE DERIVATIVES | AJINOMOTO CO., INC. (JP) | 2008-05-08 | — | — | US | disclosed |
| EP-1916241-A1 | CRYSTAL OF PHENYLALANINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME AND USE THEREOF | Ajinomoto Co., Inc. (JP) | 2008-04-30 | — | — | EP | disclosed |
| US-7345049-B2 | Phenylalanine derivatives | AJINOMOTO CO., INC. (JP) | 2008-03-18 | — | — | US | disclosed |
| EP-1700850-A1 | NOVEL PHENYLALANINE DERIVATIVE | Ajinomoto Co., Inc. (JP) | 2006-09-13 | — | — | EP | disclosed |
| US-20050222141-A1 | Novel phenylalanine derivatives | AJINOMOTO CO., INC. (JP) | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080108634-A1 | NOVEL PHENYLALANINE DERIVATIVES | ITGB4, ITGA4, ITGAV | KMT2A 1903/4885MEN1 4277/4885CRHBP 3275/4885 |
| US-20050222141-A1 | Novel phenylalanine derivatives | ITGB4, ITGA4, ITGAV | KMT2A 1903/4885MEN1 4277/4885CRHBP 3275/4885 |
| US-20110009434-A1 | CRYSTALS OF ISOPROPYL ESTER OF N-(2,6-DICHLOROBENZOYL)-4-[6-(METHYLAMINO)METHYL -1-METHYL-2,4-DIOXO-1,4-DIHYDROQUINAZOLINE-3(2H)-YL]-L- PHENYLALANINE HYDROCHLORIDE, PRODUCTION METHOD THEREOF AND USE THEREOF | ITGB4, ITGA4, ITGAL | KMT2A 1007/4885MEN1 4118/4885CRHBP 4600/4885 |
| US-20080108637-A1 | CRYSTALS OF PHENYLALANINE DERIVATIVES, PRODUCTION METHOD THEREOF AND USE THEREOF | PAH, TYR, PEPD | KMT2A 2953/4885MEN1 2119/4885CRHBP 1079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.